Lv1
30 积分 2024-10-29 加入
A Brief Overview of Global Trends in MSC-Based Cell Therapy
2个月前
已完结
Racial and Ethnic Differences in Drug Disposition and Response: Review of New Molecular Entities Approved Between 2014 and 2019
2个月前
已完结
Racial and Ethnic Differences in Drug Disposition and Response: Review of New Molecular Entities Approved Between 2014 and 2019
2个月前
已完结
Model-Informed Dosing Regimen of Sugemalimab for European Patients With Non-Small Cell Lung Cancer: Bridging From Asian Clinical Data
3个月前
已完结
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors
3个月前
已完结
Envafolimab: First Approval
4个月前
已完结
PK/PD Evaluation of Antibody–Drug Conjugates with Enhanced Immune Effector Functions
8个月前
已完结
Evaluation of Hemoglobin Response to Treatment With Enarodustat Using Pharmacometric Approach in Japanese Anemic Patients With Chronic Kidney Disease
10个月前
已完结
Integrated Population Pharmacokinetics of Daprodustat in Patients with Chronic Kidney Disease with Anemia
1年前
已完结
Pharmacokinetics, Pharmacodynamics, and Safety Evaluation of the Novel HIF-PH Inhibitor Enarodustat: An Open-Label Phase I Study in Healthy Chinese Participants
1年前
已完结
皖公网安备34019202002308
